Sponsor content
336 result(s) found, displaying 171 to 180
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Durvalumab
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Olaparib
-
Australian public assessment report (AusPar)Forxiga (dapagliflozin) has been approved for the treatment of symptomatic heart failure with reduced ejection fraction, as an adjunct to standard of care therapy, in adults.
-
Prescription medicine registrationActive ingredients: osimertinib mesilate.
-
-
-
-
-
-
Prescription medicine decision summaryAustralian prescription medicine decision summary